DC Chemicals Limited

About DC Chemicals Established in 2013 , DC Chemicals (www.dcchemicals.com) is a world-leading supplier of drug active molecules. Our Products DC Chemicals is committed to providing global drug research and development as well as medical research clients with a wide range of innovative and comprehensive high-quality small molecule active compounds. We offer over 10,000 specific inhibitors, agonists, and cationic liposomes that act on gene delivery, gene editing, RNA vaccines, epigenetics, PI3K/Akt/mTOR, apoptosis, MAPK, Wnt, and other 20 signaling pathways with more than 1,000 target proteins, covering popular disease research areas such as cancer, neuroscience, and immunology. DC Chemicals has many globally exclusive compounds and a professional team tracking new pharmaceutical and life science research progress, which can provide you with the latest research small molecule compounds to meet your research needs. Our Features As one of the earliest companies in the world to develop and research cationic liposomes, DC Chemicals provides a large number of liposomes for global RNA and gene editing companies for LNP research and screening. DC Chemicals currently has one of the largest cationic/ionizable liposome libraries in the world. Cationic liposomes are the core components of LNP and are currently the most core technology for gene delivery. Our liposomes follow the latest frontier structures and can provide clients with liposome samples from mg to g levels to facilitate clients' rapid access to liposomes for LNP research. Our Advantages Our small molecule compounds are at least 10% cheaper compared to other large reagent companies (Selleck Chemicals, Medchemexpress, etc.), and under our strict quality control, our quality is equal to or better than similar reagent companies. Especially for animal experiments that require a large amount of small molecule compounds for in vivo experiments, our price advantage is more obvious, which can save clients a lot of res